Sensus Healthcare Appoints Dr. Isabelle Raymond as Vice President, Clinical Development

New Executive Leader Brings Extensive Clinical Research, Medical Marketing and Product Launch Experience to the Company BOCA RATON, Fla., May 8, 2018 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announced the appointment of Dr. Isabelle Raymond, […]

Sensus Healthcare Reports First Quarter Financial Results Featuring 37% Revenue Growth

Ships 21 systems with SRT-100 Vision™ systems sales continuing to rise Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla., May 3, 2018 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announces financial results […]

Sensus Healthcare Appoints Rita Gable as Vice President of Sales – Oncology

New Addition to Senior Leadership Team Brings 15 Years of Marketing Experience to Supercharge Sensus’ Domestic Oncology Efforts BOCA RATON, Fla., May 1, 2018 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announced today the appointment of […]

See and Treat with the SRT-100 Vision for Skin Cancer Treatment

Superficial Radio Therapy is the premier choice for physicians and patients when it comes to skin cancer treatment options. With the SRT-100 Vision for Skin Cancer Treatment, physicians and patients alike, are privileged to witness the results through high-frequency ultrasound imaging. Key Features Laser Positioning System The SRT-100 Vision provides a laser positioning system for […]

Sensus Healthcare to Host First Quarter 2018 Financial Results and Business Update Conference Call on May 3, 2018

BOCA RATON, Fla., April 26, 2018 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announces that management will hold a conference call on Thursday, May 3, 2018 at 4:30 p.m. Eastern time to discuss the financial results […]

Sensus Healthcare Expands International Business to Meet Rising Patient Demand for Non-Invasive Skin Cancer and Keloid Treatments

EVP Rick Golin Assumes New Role Bringing Superficial Radio Therapy to International Distributors in Asia, the Americas, Europe and the Middle East BOCA RATON, Fla., April 19, 2018 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announced […]

Educating Your Patients on Keloid Removal Success Rates

A keloid is a cutaneous mass that characteristically develops following a dermal injury. The keloid has beset dermatologists and cosmetic surgeons for decades, in view of both its pathological evolution and therapeutic challenges. Classically described as an overgrowth of tissue that extends beyond the borders of the original wound, keloids differ from that of hypertrophic […]

Skin Cancer and SRT – Jeff Goldstein Interview

Jeff Goldstein is a double lung transplant recipient and a multiple skin cancer survivor. Transplant recipients are immune compromised and has a pre-disposition to skin cancer. As a Floridian, Jeff spent a lot of time out in the Miami sun without sunscreen. Due to the sun exposure leading to skin cancer, Jeff has undergone over […]

Physician Spotlight – March 2018

Daniel J. Ladd, Jr., DO is the Medical Director and Founder of Tru-Skin Dermatology in Austin, Texas and the 2018 President-Elect of the AOCD. He earned his BA from the University of Texas at Austin and received his medical degree from Des Moines University in 1999. He completed his Dermatology residency at the Northeast Regional […]

Sensus Healthcare to Present at the B. Riley FBR Inaugural China Healthcare Investing & Partnering Symposium

BOCA RATON, Fla., March 8, 2018 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), and multi-platform state of the art aesthetic lasers, today announced the Company will present at the B. Riley FBR Inaugural China Healthcare Investing […]